Furthermore, PON1 is potentially related to the MVI of liver cancer [31, 32]; therefore, given the correlation between MVI and sorafenib efficacy [33], PON1 might play a crucial role in the development of SR by influencing MVI, which agrees with the findings of the present study. This evidence concerns the gene PON1 and liver cancer.